Risk of Developing Seizures in Children With Abnormal EEG Findings During Polysomnography

Elise L Mercier1, Swati Chanchani1, Karen S Carvalho1

  • 1Section of Neurology, Department of Pediatrics, St. Christopher's Hospital for Children, Drexel University College of Medicine, Philadelphia, Pennsylvania.

Pediatric Neurology
|January 4, 2023
PubMed

Insights

Abnormal electroencephalogram (EEG) findings during polysomnography (PSG) in children without a prior epilepsy diagnosis often indicate abnormalities on routine EEG (rEEG) and an increased risk for future seizures.

Area of Science:

  • Pediatric Neurology
  • Clinical Neurophysiology

Background:

  • Polysomnography (PSG) uses abbreviated electroencephalogram (EEG) for sleep staging.
  • The diagnostic utility of EEG abnormalities detected during PSG in non-epileptic children requires further investigation.

Purpose of the Study:

  • To assess the correlation between epileptiform abnormalities on abbreviated EEG during PSG and routine EEG (rEEG) in children.
  • To determine if these EEG abnormalities predict an increased risk of seizures in children without a prior epilepsy diagnosis.

Main Methods:

  • Retrospective chart review of 67 children with EEG abnormalities during PSG, excluding those with a prior epilepsy diagnosis.
  • Analysis included subsequent routine EEG (rEEG) results and epilepsy diagnosis as primary outcomes.

Main Results:

  • Abnormal epileptiform discharges were identified in 65% of children on PSG-derived EEG.
  • Children with abnormal PSG EEG findings were significantly more likely to have abnormal rEEG results.
  • A notable proportion of these children (29%) subsequently developed seizures, with higher rates observed for generalized or mixed abnormalities.

Conclusions:

  • Abnormal EEG findings during PSG in children without a history of seizures are predictive of abnormalities on routine EEG.
  • These children face an elevated risk of developing epilepsy, underscoring the importance of follow-up evaluations.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
241
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
521
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
242